Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rimegepant for Endometriosis-Associated Pain
NCT07795125Phase 2Not yet recruiting
- Sponsor
- Mayo Clinic
- Start
- Sep 2026
- Primary completion
- Mar 2031
- Countries
- 1
01
Overview
A Phase 2 trial of rimegepant in endometriosis, sponsored by Mayo Clinic. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
rimegepant
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07795125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07795125.